HO
SanBio Co Ltd Pipeline
| Drug | Indication | Phase |
|---|---|---|
| SB623 (Acego) | Chronic Traumatic Brain Injury (TBI) | Approved (Japan) |
| SB623 | Chronic Stroke | Phase 2/3 |
| SB623 (Potential) | Other CNS Disorders (e.g., Spinal Cord Injury, Parkinson's) | Pre-clinical/Research |
| Drug | Indication | Phase |
|---|---|---|
| SB623 (Acego) | Chronic Traumatic Brain Injury (TBI) | Approved (Japan) |
| SB623 | Chronic Stroke | Phase 2/3 |
| SB623 (Potential) | Other CNS Disorders (e.g., Spinal Cord Injury, Parkinson's) | Pre-clinical/Research |